Education
Critical Care in Obstetrics Online Course 2024: Placenta Accreta Spectrum (No CME)
-
Register
- Non-member - Free!
- Regular (MFM) - Free!
- Resident - Free!
- Associate - Free!
- Associate - Fellow - Free!
- Medical Student - Free!
- Practice Professional - Free!
- Honorary - Free!
- Emeritus - Free!
- Affiliate - Free!
- Internal - Free!
- Adjunct Member - Free!
- NPWH - Allied Affiliate Membership - Free!
Already registered?
Log in now.
This Critical Care in Obstetrics Online Course module consists of the following:
Pre-test Quiz
Lecture
Lecture Slides
Case Study
Post-test Quiz
Upon completion of the components in this topic, the learner will be able to:
- Discuss the incidence, risk factors, and prediction of placenta accreta spectrum disorders.
- Discuss the management options for patients with suspected placenta accreta.
- Discuss the intrapartum management of patients with placenta accreta, and available treatment for managing common complications.
This module expires on January 15, 2025
Key:
Complete
Next
Failed
Available
Locked
Placenta Accreta Spectrum Pre-Test Quiz
7 Questions | 1 attempt | 5/7 points to pass
7 Questions | 1 attempt | 5/7 points to pass
Placenta Accreta Spectrum Lecture
Open to view video.
Open to view video.
Lecturer:
Christopher Kevin Huls, MD, MSc
Clinical Assistant Professor University of Arizona COM-Phoenix
Lecture Objectives
1. Discuss the incidence, risk factors, and prediction of placenta accreta spectrum disorders
2. Discuss the management options for patients with suspected placenta accreta
3. Discuss the intrapartum management of patients with placenta accreta, and available treatment for managing common complications
References
1. Clark SL, Koonings PP, Phelan JP. Placenta previa/accreta and prior cesarean section. Obstet Gynecol 1985;66:89‐92.
2. Silver RM, Landon MB, Rouse DT, Leveno KJ, Song CY, Thom EA, et al. Maternal morbidity associated with multiple repeat cesarean delivery. Obstet Gynecol 2006;107:1226‐32.
3. Saito M, Ishihara K, Sekiya T, Araki T: Anticipation of uterine bleeding in placenta previa based on vaginal sonographic evaluation. Gynecol Obstet Invest 2002:54(1):37‐42.
4. Chou MM, Ho ES. Prenatal diagnosis of placenta previa/accreta with power amplitude ultrasonic angiography. Am J Obstet Gynecol 1997 Dec: 177(6):1523‐5.
5. Zaki ZM, Bahar AM, Ali ME, Albar HA, Gerais MA. Risk factors and morbidity in patients with placenta previa accreta compared to placenta previa non-accreta. Acta Obstet Gynecol Scand 1998;77:391‐4. (Level II-3)
6. Kirkinen P, Helin-Martikainen HL, Vanninen R, Partanen K. Placenta accreta: imaging by gray-scale and contrast-enhanced color Doppler sonography and magnetic resonance imaging. J Clin Ultrasound 1998;26:90‐4. (Level III)
7. Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG. 2009 Apr;116(5):648-54. doi: 10.1111/j.1471-0528.2008.02037.x. Epub 2009 Feb 4.
8. ACOG committee opinion 529, Placenta Accreta, July 2012
Placenta Accreta Spectrum Case Study
5 Questions | 3 attempts | 4/5 points to pass
5 Questions | 3 attempts | 4/5 points to pass
Placenta Accreta Spectrum Post-Test Quiz
7 Questions | 3 attempts | 5/7 points to pass | Graded as Pass/Fail
7 Questions | 3 attempts | 5/7 points to pass | Graded as Pass/Fail